Immunological markers anti-saccharomyces cerevisiae antibodies (ASCA) and anti-neutrophil cytoplasmic antibodies (ANCA) in inflammatory bowel disease: A helpful diagnostic tool

Minerva Gastroenterologica e Dietologica

Volumn 51, Issue 2, 2005, Pages 201-207

  Montanelli, A ^a   Mainardi, E ^a   Vagni, A ^a   Villanacci, V ^b   Zambelli, C ^b   Cestari, R ^b   Cengia, P ^b   Minelli, L ^b   Missale, G ^b  

^a MAGGIORE HOSPITAL   (Italy)

^b UNIVERSITY OF BRESCIA   (Italy)

Author keywords

Anti neutrophil cytoplasmic antibodies; Crohn disease; Saccharomyces Cerevisiae; Ulcerative colitis

Indexed keywords

DIFFERENTIATION ANTIGEN; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; NEUTROPHIL CYTOPLASMIC ANTIBODY; FUNGUS ANTIBODY;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; CROHN DISEASE; DIAGNOSTIC PROCEDURE; ENDOSCOPY; ENTERITIS; ENZYME LINKED IMMUNOSORBENT ASSAY; EVALUATION; FEMALE; HISTOPATHOLOGY; HUMAN; IMMUNOFLUORESCENCE; INTERMETHOD COMPARISON; MALE; RADIOLOGY; SACCHAROMYCES CEREVISIAE; SENSITIVITY AND SPECIFICITY; SERODIAGNOSIS; ULCERATIVE COLITIS; BLOOD; DIFFERENTIAL DIAGNOSIS; FLUORESCENT ANTIBODY TECHNIQUE; IMMUNOLOGY; MIDDLE AGED; PATHOLOGY;

ADULT; AGED; ANTIBODIES, ANTINEUTROPHIL CYTOPLASMIC; ANTIBODIES, FUNGAL; DIAGNOSIS, DIFFERENTIAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; HUMANS; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; INFLAMMATORY BOWEL DISEASES; MALE; MIDDLE AGED; SACCHAROMYCES CEREVISIAE;

EID: 26944445487     PISSN: 00264776     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Lennard-Jones JE. Classification of inflammatory bowel disease. Scand J Gastroenterol 1989;24 Suppl:2-6.
2. Hamilton SR. The differential diagnosis of idiopathic inflammatory bowel disease by colorectal biopsy. Int J Colorectal Dis 1987;2:113-7.
3. Nicholls RJ, Wells AD. Indeterminate colitis. Baillieres Clin Gastroenterol 1992;6:105-12.
4. Schachter H, Kirsner JB. Definitions of inflammatory bowel disease of unknown aetiology. Gastroenterology 1975;68:591-600.
5. Meucci G, Bortoli A, Riccioli FA, Girelli CM, Radaelli F, Rivolta R et al. Frequency and clinical evaluation of indeterminate colitis: A retrospective multi-centre study in northern Italy. Eur J Gastroenterol Hepatol 1999;11:909-13.
6. Lennard-Jones JE, Shivananda S and the EC-IBD study group. Clinical uniformity of inflammatory bowel disease at presentation and during the first year of disease in the north and south of Europe. Eur J Gastroenterol Hepatol 1997;9:353-9.
7. Hildebrand H, Fredrikzon B, Holmquist L, Kristiansson B, Lindquist B. Chronic inflammatory bowel disease in children and adolescents in Sweden. J Pediatr Gastroenterol Nutr 1991;13:293-7.
8. Riegler G, Arimoli A, Esposito P, Iorio R, Carratu R. Clinical evolution in an outpatient series with indeterminate colitis. Dis Colon Rectum 1997;40:437-9.
9. Geboes K, Ectors N. Diagnosis of ulcerative colitis in endoscopic biopsies. Hepatogastroenterol 1989;36:188-92.
10. Theodossi A, Spiegelhalter DJ, Jass J, Firth J, Dixon M, Leader M et al. Observer variation and discriminatory value of biopsy features in inflammatory bowel disease. Gut 1994;35:961-8.
11. Rump JA, Scholmerich J, Gross V, Roth M, Helfesrieder R, Rautmann A et al. A new type of perinuclear antineutrophil cytoplasmic antibody (p-ANCA) in active ulcerative colitis but not in Crohn's disease. Immunobiol 1990;1:406-13.
12. Peen E, Almer S, Bodemar G, Ryden BO, Sjolin C, Tejle K et al. Anti-lactoferrin antibodies and other types of ANCA in ulcerative colitis primary sclerosing cholangitis and Crohn's disease. Gut 1993;34:56-62.
13. Quinton JF, Sendid B, Reumaux D, Duthilleul P, Cortot A, Grandbastien B et al. Anti-Saccharomyces cerevisiae mannan antibodies combined with antineutrophil cytoplasmic autoantibodies in inflammatory bowel disease: Prevalence and diagnostic role. Gut 1998;42:788-91.
14. Jenkins D, Balsitis M, Gallivan S, Dixon MF, Gilmour HM, Sheperd NA et al. Guidelines for the initial biopsy diagnosis of suspected chronic inflammatory bowel disease. The British Society of Gastroenterology Initiative. J Clin Pathol 1997;50:93-105.
15. Jewell PD, Warren BF, Mortensen NJ. Challenges in inflammatory bowel disease, Philadelphia: Blackwell Science, 2001.
16. Roozendaal C, Kallenberg CGM. Are anti-neutrophil cytoplasmic antibodies (ANCA) clinically useful in inflammatory bowel disease (IBD)? Clin Exp Immunol 1999;116:206-13.
17. Sendid B, Colombel F, Jacquinot PM, Faille C, Fruit J, Cortot A et al. Specific antibody response to oligomannosidic epitopes in Crohn's disease. Clin Diagn Lab Immunol 1996;3:219-26.
18. Savige J, Gillis D, Benson E, Davies D, Esnault V, Falk RJ et al. International consensus statement on testing and reporting of antineutrophil cytoplasmic antibodies (ANCA). Am J Clin Path 1999;112:507-13.
19. Kaneko K, Suzuki Y, Yamashiro Y, Yabuta K. Is P-ANCA in ulcerative colitis directed against Beta-glucuronidase? Lancet 1993;341:320.
20. Sobajima J, Ozaki S, Osakada F, Uesugi H, Shirakawa H, Yoshida M et al. Novel autoantigens of perinuclear anti-neutrophil cytoplasmic antibodies (P-ANCA) in ulcerative colitis: non-histone chromosomal proteins HMG1 and HMG2. Clin Exp Immunol 1997;107:135-40.
21. Billing P, Tahir S, Calfin B, Gagne G, Cobb L, Targan S et al. Nuclear localization of the antigen detected by ulcerative colitis associated perinuclear antineutrophil cytoplasmic antibodies. Am J Pathol 1995;147:979-87.
22. Vermeire S, Joossens S, Peeters M, Monsuur F, Marien G, Bossuyt X et al. Comparative study of ASCA (anti-Saccharomyces cerevisiae antibody) assays in inflammatory bowel disease. Gastroenterology 2001;120:827-33.
23. Joossens S, Reinisch W, Vermeire S. The value of anti-Saccharomyces Cerevisiae antibodies and perinuclear anti-neutrophil cytoplasmic antibodies in indeterminate colitis: a prospective follow-up study. Gastroenterology 2002;12:1242-7.